Zoetis Inc. ( ZTS) - Key Metrics
ZTS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $5.45 | $1.38 | $2.04 | $1.67 |
| 2025Q3 | $5.42 | $1.63 | $2.12 | $1.82 |
| 2025Q2 | $5.53 | $1.61 | $1.09 | $0.69 |
| 2025Q1 | $4.96 | $1.41 | $1.31 | $0.98 |
ZTS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 36.48% | 22.86 |
| 2025Q3 | 30.79% | 22.47 |
| 2025Q2 | 31.06% | 24.17 |
| 2025Q1 | 35.50% | 29.20 |
ZTS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.58% | ? |
| 2025Q4 | 1.33% | 0.40% |
| 2025Q3 | 1.24% | 0.34% |
| 2025Q2 | 0.44% | 0.32% |
| 2025Q1 | 0.59% | 0.30% |
ZTS
List: Contenders
Price: $75.24
Dividend Yield: 2.73%
Forward Dividend Yield: 2.81%
Payout Ratio: 33.88%
Dividend Per Share: 2.12 USD
Earnings Per Share: 6.10 USD
P/E Ratio: 12.19
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.6 million
Ebitda: 543.0 millionMarket Capitalization: 31.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 16.41%
DGR5: 20.50%
DGR10: 20.83%